Research Paper Volume 16, Issue 7 pp 6163—6187
KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer
Figure 8. Correction between KIF3C expression and drug sensitivity in gastric cancer. *p < 0.05; **p < 0.01; ***p < 0.001.